Compare Tenet Healthcare Corporation (THC) vs Tesla, Inc. (TSLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tenet Healthcare Corporation vs Tesla, Inc. — how do they compare? Tenet Healthcare Corporation trades at $196.03 (market cap $16.74B), while Tesla, Inc. trades at $379.58 (market cap $1.39T). The key difference: Tesla, Inc. is far larger — about 83× Tenet Healthcare Corporation's market cap. Which is the better fit depends on your goals.
| THC | TSLA | |
|---|---|---|
Market Cap | $16.74B | $1.39T |
Sector | Health | Consumer Cyclical |
52-Week High | $244.80 | $489.88 |
52-Week Low | $148.38 | $302.63 |
Enterprise Value | $26.99B | $1.36T |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tenet Healthcare (THC) trades at $194.38, down 0.27% on the day, with a neutral technical signal despite strong fundamental performance. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $4.82 exceeding expectations of $4.17. Valuation metrics appear attractive with a P/E of 10.14 and P/S of 0.79, while profitability remains robust with 82.47% gross margins and 37.87% ROE. Recent news highlights the company's expanding outpatient footprint through USPI as a key growth driver.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and a $235.88 price target representing 21% upside potential. The company's solid earnings momentum and defensive healthcare positioning during market volatility provide stability. Key risks include execution challenges in outpatient expansion and potential regulatory headwinds affecting hospital operations. Cash flow trends show improvement with projected net cash flow narrowing from -$136M in 2025 to -$32M in 2026.
Tesla trades at $378.99, down 0.49% on the day, with a bearish technical signal from moving averages but neutral oscillators. The stock shows elevated valuation ratios (P/E 339.06, P/S 13.34) despite recent earnings beats in Q4 2025 and Q1 2026. Revenue declined to $94.83B in 2025, with net income margin compressing to 3.95%. Positive developments include regulatory approval for driver-assistance software in Europe and a potential cheaper EV model, though delivery misses and competitive pressures weigh on sentiment.
Tesla's outlook balances innovation in autonomy and energy against slowing auto growth and high valuations. The consensus price target of $409.26 suggests modest upside, but risks include execution on robotaxis, margin pressure, and macroeconomic headwinds. Institutional ownership shifts and mixed analyst ratings (38% Buy, 43% Hold) reflect cautious optimism, with the stock's trajectory hinging on AI and energy segments offsetting EV deceleration.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →About Tesla, Inc.
Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →
